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1. Introduction  
Nucleotide excision repair (NER) represents a central cellular process for the removal of 
structurally and chemically diverse DNA lesions [Friedberg et al., 2006]. Mutations in genes 
involved in NER are associated with rare autosomal recessive syndromes such as xeroderma 
pigmentosum (XP), a condition characterized by sensitivity to UV light, neurological 
abnormalities, and a propensity to develop skin cancer (Cleaver, 2005). The observation that 
cells from XP subgroup E (XP-E cells XP2RO and XP3RO) are defective in recognizing 
damaged DNA and performing NER highlighted the physiological importance of the 
protein termed DNA damage-binding protein, or DDB [Chu & Chang, 1988]. The DDB 
protein, sometimes also referred to as UV-DDB due to its high affinity and specificity for 
UV-damaged DNA, contains two principal subunits, DDB1 and DDB2 [Grossman, 1976; 
Keeney et al., 1993; Takao et al., 1993]. The DDB protein complex also binds to non-UV-
damaged DNA, like cisplatin-modified DNA, although with much lower affinity. Although 
the history of DDB spans more than two decades, the complete understanding of its 
physiological functions remains to be clarified. The activity of DDB has been repeatedly 
described in crude mammalian cell extracts by electrophoretic mobility shift assays or filter-
binding assays performed by different laboratories since the first report of its discovery 
[Feldberg & Grossman, 1976]. Notably, micro-injections of DDB complexes into the nucleus 
of XP-E cells restored NER activity [Keeney et al., 1994], supporting the notion that DDB 
participates in chromatin NER. The DDB1 gene from simian cells was the first DDB gene to 
be identified [Takao et al., 1993]. The human DDB1 and DDB2 genes were subsequently 
sequenced [Dualan et al., 1995; Lee et al., 1995]. Soon after, DNA sequencing from Linn’s 
laboratory revealed that DDB2 is mutated in XP-E cells which lack DDB activity [Nichols et 
al., 1996; Tang & Chu, 2002]. The predicted DDB2 protein sequence was shown to contain 
several functional domains, including WD40 repeats, post-translation modification sites (e.g. 
acetylation, phosphorylation, and ubiquitination), DDB1- and DNA-binding sites, as well as 
a DWD box. Notably, in a majority of XP-E cell lines, DDB2 was found to be altered at 
domains other than the one required for binding DNA. Thus, DDB appears to be regulated 
at several levels in UV-irradiated cells, including by transcriptional activation of DDB2 
mRNA, post-translational modification, translocation to the nucleus, complex formation, 
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and proteolytic degradation of DDB2 protein through ubiquitination [for a recent review, 
see Sugasawa, 2010]. Notably, 60% of chromatin-bound DDB2 is degraded within 4 hrs of 
UV irradiation. After 48 hrs, DDB2 mRNA levels increase several fold above the level seen 
in non-irradiated cells [Nichols et al., 2000; Rapic-Otrin et al., 2002]. Interestingly, the 
majority of UV-induced DNA photoproducts in human cells are repaired by this time 
[Mitchell et al., 1985]. 
2. DDB2 recognizes DNA damage during global genome NER 
NER removes diverse DNA lesions, ranging from UV-induced cyclobutane pyrimidine dimers 
(CPD) and 6-4 pyrimidine-pyrimidone photoproducts (6-4PP) to a variety of bulky adducts 
formed by environmental carcinogens. Mammalian NER comprises global genome NER (GG-
NER) and transcription-coupled NER (TC-NER). These two processes involve similar but 
distinct repair proteins that process DNA damage and chromatin proteins like histones may 
significantly regulate the activity of repair proteins (reviewed by Friedberg et al., 2006). One 
such multiprotein complex involved in GG-NER and containing both DDB1 and DDB2 is 
closely related to a complex containing DDB1 and the Cockayne syndrome group A (CSA) 
protein in TC-NER. In GG-NER, DNA is initially surveyed for lesions by XP group C (XPC) 
protein-RAD23B (Sugasawa et al., 1998) and the UV-DDB complex (Fitch et al., 2003; Moser et 
al., 2005; Sugasawa et al., 2005). DDB2 binds to DDB1 to form the DDB complex which may 
recognize UV-induced DNA damage and recruit proteins of the NER pathway to initiate GG-
NER (Hwang et al., 1999; Tang et al., 2000). The DDB complex preferentially binds to UV-
induced CPD, 6-4PP, apurinic sites, and short mismatches (Fujiwara et al., 1999; Kulaksiz et al., 
2005; Sugasawa et al., 2005; Wittschieben et al., 2005). While XPC functions as a versatile factor 
that senses abnormal DNA structures, DDB appears to recognize more specific types of 
lesions, particularly UV-induced 6-4PP, whereas binding to CPD is much weaker but 
nonetheless detectable [Payne & Chu, 1994]. Strikingly, structural analysis of DDB bound to 
DNA duplex containing 6-4PP has revealed that the DDB2 subunit is responsible for the 
interaction, and this subunit induces the movement of the two affected bases into a binding 
pocket, therefore indicating that DDB has evolved to specifically recognize dinucleotide 
lesions, like UV photolesions [Figure 1; Scrima et al., 2008]. Furthermore, accumulating 
evidence has confirmed the existence of multiple forms of DDB2 mRNA splicing variants, 
including isoforms D1 and D2, which do not interact with DDB1, but inhibit UV-damaged 
DNA repair (Inoki et al., 2004). DDB2 is ubiquitously expressed in human tissues, with the 
highest level being found in corneal endothelium and the lowest level in the brain. Isoform D1 
is highly expressed in brain and heart tissues, whereas isoforms D2, D3, and D4 are weakly 
expressed in these tissues (Inoki et al., 2004). Interestingly, repair of DNA damage induced by 
UV light appears to be less active in brain and heart tissues which are naturally protected 
against UV irradiation and express high levels of isoform D1. 
3. DDB2 links DNA repair to protein ubiquitination 
Another breakthrough that links protein ubiquitination with GG-NER is the finding that 
DDB is part of an ubiquitin ligase (E3) complex. Epitope-tagged DDB2 purified from cells 
was found in complex with CUL4A, ROC1, DDB1, and the COP9 signalosome [Groisman et 
al., 2003]. Besides its function as part of the DDB-protein complex, DDB2 may function as a 
substrate-recognition module within the CUL4A ubiquitination complex. CUL4 is one of  
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Fig. 1. Overall structure of the DDB1-DDB2-DNA complex. Ribbon representation of the 
DDB-DNA6-4PP complex: DDB2; DDB1-BPA; DDB1-BPB; DDB1-BPC; DDB1-CTD. The DNA6-
4PP damaged and undamaged DNA strands are depicted in black and gray, respectively. 
DNA binding is carried out exclusively by the DDB2 subunit via its WD40 domain. The 
DDB1 structure consists of three WD40 β-propeller domains (BPA, BPB, and BPC) and a C-
terminal helical domain (CTD, shown at the center). DDB2 binds to an interface between the 
DDB1 propellers BPA and BPC, where its helix-loop-helix motif inserts into a cavity formed 
by the two propellers. The structures reveal the molecular mechanism underlying high-
affinity recognition of UV lesions (damaged DNA strand) that are refractory to detection by 
XPC. The structures also suggest a mechanism for the assembly of the DDB-CUL4 ubiquitin 
ligase in chromatin and provide a framework for understanding the ubiquitination of 
proteins proximal to damage sites. [For detail, see Scrima et al., 2008]. 
three founding cullins that are conserved from yeast to humans. A large number of E3 
ubiquitin-protein ligase complexes are part of the DCX proteins (short for DDB1-CUL4-X-
box). Components of the CUL4-DDB-ROC1 (also known as CUL4-DDB-RBX1) include 
CUL4A or CUL4B, DDB1, DDB2, and RBX1 (Chen et al., 2001; Groisman et al., 2003). Other 
CUL4-DDB-ROC1 complexes may also exist in which DDB2 is replaced by a subunit that 
targets an alternative substrate. These targeting subunits are generally known as DCAF 
proteins (short for DDB1- and CUL4-associated factor) or CDW (short for CUL4-DDB1-
associated WD40-repeat; for reviews, see Lee & Zhou, 2007; Jackson & Xiong, 2009; 
Sugasawa, 2009). Many CUL4 complexes are involved in chromatin regulation and are 
frequently hijacked by viruses (reviewed by Jackson & Xiong, 2009). The DDB1-CUL4-ROC1 
complex may ubiquitinate histones H2A, H3, and H4 at sites of UV-induced DNA damage 
(Wang et al., 2006; Kapetanaki et al., 2006; Guerrero-Santoro et al., 2008). The ubiquitination 
of histones may facilitate their removal from the nucleosome and promote assembly of NER 
components for subsequent DNA repair. Furthermore, the DDB1-CUL4-ROC1 complex 
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ubiquitinates XPC and DDB2, which may enhance DNA binding by XPC and promote NER 
(El-Mahdy et al., 2006; Sugasawa et al., 2005). Structural analysis support the notion that 
CUL4 uses DDB1 as a large β-propeller protein and as a linker to interact with a subset of 
WD40 proteins like DDB2, which serves as substrate receptors, forming as many as 90 E3 
complexes in mammals [Jackson & Xiong, 2009]. Taken together, these results indicate that 
DDB complex is a component of the CUL4A-based ubiquitin ligase DDB1-CUL4ADDB2, and 
that DDB2 may coordinate the ubiquitination of various proteins at DNA damage sites 
during GG-NER. 
In addition, CUL4B also binds to UV-damaged chromatin as a part of the DDB1-CUL4BDDB2 
E3 ligase in the presence of functional DDB2. Nevertheless, CUL4B is localized in the 
nucleus and facilitates the transfer of DDB1 into the nucleus independently of DDB2 
[Guerrero-Santoro et al., 2008]. Notably, DDB1-CUL4BDDB2 is more efficient than DDB1-
CUL4ADDB2 in mono-ubiquitinating histone H2A in vitro, suggesting that the DDB1-
CUL4BDDB2 E3 ligase may have a distinctive function in modifying the chromatin structure 
at sites of UV lesions and promoting efficient GG-NER. Intriguingly, the CSA protein, a 
WD40 motif protein defective in a complementation group of Cockayne’s syndrome, forms 
a similar E3 complex in place of DDB2 at damage sites during TC-NER. Although not 
detected in the DDB2 and CSA complex, CUL4B is highly expressed in mammalian cells, 
and the two CUL4 isoforms CUL4A and CUL4B appear to be redundant, at least for some 
cellular functions [Higa et al., 2003; Hu et al., 2004]. 
4. DDB2 inhibits apoptosis in cultured cell lines and Drosophila 
Although the regulation of the DDB2 gene is complex, evidence on the biological function of 
DDB2 in response to apoptotic stimuli has accumulated. Evidence from biochemical 
experiments has shown how DDB2 interacts with proteins, DNAs, and RNAs. Most strikingly, 
structural studies using X-ray crystallography support the evidence of biochemical studies, as 
seen for example with GG-NER. Nevertheless, a complete understanding of the biological 
roles of DDB2 remains to be fully elucidated. To assess this question, we explored the role of 
DDB2 in regulating UV sensitivity in both human cells and Drosophila [Sun et al., 2010]. As 
such, a full-length DDB2 open reading frame sequence was overexpressed in cells that express 
low or no DDB2. Conversely, DDB2 expression was suppressed in cells that endogenously 
express high levels of DDB2 by stable expression of full-length anti-sense cDNA. Using this 
strategy, we found that DDB2 displays a protective role against UV irradiation and cell surface 
death receptor signaling in both cisplatin-selected human HeLa cells and hamster V79 cells 
[Sun et al., 2002a; Sun et al., 2002b; Sun & Chao, 2005a]. Furthermore, cFLIP expression was 
upregulated by DDB2 in a dose- and time-dependent manner in HeLa cells, a process 
associated with inhibition of apoptosis [Sun & Chao, 2005a]. Inhibition of cFLIP by anti-sense 
oligonucleotides substantially inhibited apoptosis induced by UV irradiation and death 
receptor signaling in HeLa and other cell lines. Importantly, the protective effect of DDB2 was 
only detected in cells in which cFLIP is elicited during apoptotic stimuli. In contrast, DDB2 did 
not show a protective effect against apoptotic stimuli in human cell lines in which cFLIP 
expression was not induced [Sun et al., 2010]. A transcription reporter assay also showed that 
DDB2 induces the transcription of cFLIP in a p38/MAPK-dependent manner [Sun & Chao, 
2005b], suggesting that the DDB2/cFLIP pathway may be active in specific cell conditions 
[Figure 2]. Surprisingly, overexpression of a DDB2 mutant (82TO) that does not significantly 
enhance DDB activity (Nichols et al., 1996), also protected HeLa cells from both UV- and Fas-
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induced cell death (Sun et al., 2002a; Sun & Chao, 2005a), suggesting that the protection effect 
of DDB2 may be independent of its DNA repair activity. Furthermore, ectopic expression of 
human DDB2 in Drosophila dramatically reduced UV-induced animal death compared to 
control GFP expression. On the other hand, expression of DDB2 in Drosophila failed to rescue a 
different type of apoptosis induced by the genes reaper or eiger [Sun et al., 2010]. Depletion of 
DDB2 in HeLa cells did not affect apoptosis induced by cisplatin or mitomycin C (Sun et al., 
2002a). In addition, overexpression or inhibition of DDB2 in HeLa cells only slightly affected 
cisplatin-induced caspase-8 signaling and apoptosis (Sun & Chao, 2005a), probably due to the 
observation that cisplatin primarily induces mitochondrial apoptotic signaling (Gonzalez et al., 
2001). These observations suggest that the modulation of apoptosis by DDB2 may be unique. 
 
 
Fig. 2. Model illustrating the role of DDB2 in regulating non-DNA damage-induced 
apoptosis. An anti-apoptotic effect is proposed for DDB2 against death ligand- or UV-
induced stress through cFLIP up-regulation. DDB2 transactivation of cFLIP is required to 
enhance their apoptosis-inhibitory function. UV- or death receptor-induced apoptosis is 
attenuated by the up-regulated cFLIP; consequently, activation of initiator caspases  
(3 and 7), cleavage of protein substrates (PARP and DFF), and apoptosis are inhibited.  
DDB2 may also attenuate UV-induced apoptosis through repair of DNA damage. However, 
evidence from protective DDB2 mutants suggests possible alternative pathways. DL, death 
ligands; DR, death receptors. [Modified from Sun and Chao, 2005a] 
Cross-resistance to UV was found in cisplatin-selected cells, which overexpress DDB2 [Chu & 
Chang, 1990; Chao et al., 1991]. DDB2 is a transcriptional partner of E2F1; however, the target 
of DDBs/E2F1 has not been identified (Hayes et al., 1998; Shiyanov et al., 1999). We found that 
the overexpression of DDB2 increases the expression of cFLIP at both the mRNA and protein 
levels in resistant cells in which DDB2 has been genetically suppressed [Sun and Chao, 2005a]. 
E2F1 was also shown to regulate the expression of cFLIP (Stanelle et al., 2002). Therefore, 
cFLIP may represent the first potential target of DDB2/E2F1. E2F1 promotes TNF-induced 
apoptosis by stabilizing the TRAF2 protein (Phillips et al., 1999). However, the possibility that 
DDB2/E2F1 may co-activate cFLIP expression suggests a possible dual role for E2F1 in 
regulating cell survival and death. Additional overexpression of E2F1 does not increase 
endogenous cFLIP expression more than overexpression of DDB2 alone (Peng, 2008). Thus, the 
increased level of E2F1 observed in resistant cells is not enough to support the apoptotic 
resistance mediated by DDB2-cFLIP. Although induction of cFLIP by DDB2 is required to 
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protect cells against UV-induced apoptosis, at least in HeLa cells, we could not exclude the 
possibility that other genes are also involved in mediating the anti-apoptotic effect of DDB2. 
5. Ectopic expression of DDB2 induces apoptosis in DDB2-deficient cells 
An extensive review of XP-E and DDB has been presented by Itoh who focused on XP-E and 
DDB2 as well as the classification of photosensitive diseases [Itoh, 2006]. Surprisingly, XP-E 
cell strains proved to be abnormally resistant to UV irradiation and possessed reduced 
caspase-3 activity. Since the apoptotic defect in XP-E strains could be rescued by exogenous 
p53 expression, DDB2 was also proposed to regulate p53-mediated apoptotic pathway after 
UV irradiation in human primary cell strains [Itoh et al, 2000; 2003]. Cells from DDB2-
knockout mice also showed abnormal resistance and impaired p53 response to UV 
irradiation similar to human XP-E cell strains [Itoh et al., 2004]. Furthermore, a recent study 
has demonstrated that mouse embryonic fibroblasts and human HeLa that express DDB2 
shRNA are resistant to apoptosis induced by a variety of DNA-damaging agents despite the 
activation of p53 and other pro-apoptotic genes [Stoyanova et al., 2009]. Also, these DDB2-
deficient cells are resistant to E2F1-induced apoptosis, probably due to the observation that 
these cells undergo p21Waf1/Cip1-associated cell cycle arrest following DNA damage. 
Notably, DDB2 targets p21Waf1/Cip1 for proteolysis and this process involves Mdm2 in a 
manner that is distinct from the p53-regulatory activity of Mdm2 [Stoyanova et al., 2009]. 
These results suggest a new regulatory loop involving DDB2, Mdm2, and p21Waf1/Cip1 
that is critical in determining the cellular fate between apoptosis and cell cycle arrest (for 
DNA repair) in response to DNA damage. The existence of this regulatory loop may be 
strengthened by showing that forced expression of DDB2 renders XP-E or DDB2-deficient 
cells sensitive to apoptotic stimuli. 
6. Cancer-prone DDB2-deficient mice 
DDB2-knockout mice have been shown to be prone to cancer formation [Itoh et al., 2004]. 
Importantly, mice with single DDB2 allele knockout showed enhanced skin cancer following 
UV-B exposure, suggesting that DDB2 heterozygotes may be predisposed to skin cancer 
[Itoh et al., 2004]. In addition, XP mouse models were reported to be prone to the formation 
of papillomas induced by 7,12-dimethylbenz[a]anthracene (DMBA) [de Bohr et al., 1999; 
Nakane et al., 1995; de Vries et al., 1995], a carcinogen that produces bulky DNA adducts 
usually repaired by the NER system. On the other hand, p53-knockout mice are prone to 
spontaneous tumors [Donehower et al., 1992; Jacks et al., 1994], but not to tumors induced 
by DMBA or 12-O-tetradecanoyl-phorbol-13-acetate (TPA) [Kemp et al.,1993]. Taken 
together, these observations suggest that DDB2 may be involved in cancer formation 
through p53-mediated pathways. However, it is unclear whether re-introducing DDB2 in 
DDB2-knockout mice may prevent cancer formation. 
7. Concluding remarks and future perspectives 
The various results cited above suggest that the genetic integrity or gene expression status of 
the cells may be critical in determining the regulatory effects of DDB2 in response to 
apoptotic stimuli. The level of DDB2, p53, E2F1, and other proteins such as anti-apoptotic 
cFLIP and cell-cycle arrest p21, for instance, should be considered. The pro-apoptotic 
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activity of p53 could vary between primary and cultured cell lines. For example, p53 activity 
in HeLa cells is hijacked by the human papillomavirus (HPV) E6 protein, a process that 
weakens apoptotic signaling in these cells. High levels of DDB2 may up-regulate and 
potentiate p53 activity by up-regulating apoptotic proteins in p53-normal cells. As such, 
HeLa cells, which harbor nearly null-p53 activity and additional anti-apoptotic cFLIP 
activity elicited by DDB2, may become resistant to apoptosis in response to cytotoxic DNA 
damage. These cellular responses are not surprising if the cultured cell lines were 
transformed by viruses or chemical means. Unfortunately, the cell lines used for the studies 
mentioned above are often treated this way. Furthermore, the expression of DDB2 isoforms, 
including the inhibitory D1 isoform, is often overlooked and the differential expression of 
such isoforms may dictate the cellular responses observed. Accordingly, alternative splicing 
of DDB2 transcripts and alteration of these genetic factors by other means in cell lines must 
be considered while evaluating the role of DDB2 in regulating apoptosis. In fact, there is no 
evidence so far that the apoptotic resistance of DDB2-defective XP-E, DDB2-knockout 
mouse cells, or DDB2-deficient human cells could be rescued by re-introducing DDB2 
expression. In this sense, DDB2 is required to suppress apoptosis, but it does not suffice to 
be apoptotic. Furthermore, DDB2 as a proteasome component can target various proteins, 
such as p21 which is involved in cell cycle arrest, subsequently dysregulating cell cycle 
arrest during stress repair and leading to apoptosis. The cisplatin-selected HeLa cells used 
in our study do not display G1 arrest following mild, repairable DNA damage [Lin-Chao & 
Chao, 1994], which may explain the negligible, pro-apoptotic influence of DDB2 found by 
others [Stoyanova et al., 2009]. Therefore, an updated model is proposed in Figure 3, in 
 
 
Fig. 3. Updated model for the regulation of DNA damage-induced apoptosis by DDB2. In this 
model, DNA damage applied to cells was mild and reached repairable level, leading to 
inhibition of apoptosis and cell cycle arrest for stress repair. The regulatory effect of DDB2 can 
be pro-apoptotic in cells experiencing mild DNA damage through p21 degradation which is 
targeted by DDB2. On the other hand, DDB2 can also be anti-apoptotic in cells harboring non-
DNA damage apoptotic stimuli (e.g., death receptor) with up-regulation of anti-apoptotic 
cFLIP. Accordingly, the final outcome may be influenced by intrinsic mutations or extrinsic 
viral hijacking that can impair checkpoint for G1 arrest via p53 and p21. 
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which the regulatory effect of DDB2 can be either pro-apoptotic in cells that respond to mild 
DNA damage or anti-apoptotic in cells that respond to non-DNA damage apoptotic stimuli 
and that show up-regulation of the anti-apototic cFLIP. Notably, we found that human 
DDB2 may play a protective role against UV irradiation in the fruit fly Drosophila which 
does not express DDB2 as seen in the DDB2-defective cultured cell models. Therefore, the 
seemingly contrasting results mentioned above may be explained by our models, and 
primary cell cultures which are more representative of in vivo situations may represent a 
better choice for future studies of the biological functions of DDB2. 
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